122 related articles for article (PubMed ID: 15317453)
1. Molecular recognition in purinergic receptors. 2. Diastereoselectivity of the h-P2Y1-receptor.
Major DT; Nahum V; Wang Y; Reiser G; Fischer B
J Med Chem; 2004 Aug; 47(18):4405-16. PubMed ID: 15317453
[TBL] [Abstract][Full Text] [Related]
2. Molecular recognition in purinergic receptors. 1. A comprehensive computational study of the h-P2Y1-receptor.
Major DT; Fischer B
J Med Chem; 2004 Aug; 47(18):4391-404. PubMed ID: 15317452
[TBL] [Abstract][Full Text] [Related]
3. Opposite diastereoselective activation of P2Y1 and P2Y11 nucleotide receptors by adenosine 5'-O-(alpha-boranotriphosphate) analogues.
Ecke D; Tulapurkar ME; Nahum V; Fischer B; Reiser G
Br J Pharmacol; 2006 Oct; 149(4):416-23. PubMed ID: 16953187
[TBL] [Abstract][Full Text] [Related]
4. Subtype specific internalization of P2Y1 and P2Y2 receptors induced by novel adenosine 5'-O-(1-boranotriphosphate) derivatives.
Tulapurkar ME; Laubinger W; Nahum V; Fischer B; Reiser G
Br J Pharmacol; 2004 Jul; 142(5):869-78. PubMed ID: 15197109
[TBL] [Abstract][Full Text] [Related]
5. Agonist binding and Gq-stimulating activities of the purified human P2Y1 receptor.
Waldo GL; Harden TK
Mol Pharmacol; 2004 Feb; 65(2):426-36. PubMed ID: 14742685
[TBL] [Abstract][Full Text] [Related]
6. Binding affinity difference induced by the stereochemistry of the sulfoxide bridge of the cyclic peptide inhibitors of Grb2-SH2 domain: NMR studies for the structural origin.
Shi YH; Song YL; Lin DH; Tan J; Roller PP; Li Q; Long YQ; Song GQ
Biochem Biophys Res Commun; 2005 May; 330(4):1254-61. PubMed ID: 15823578
[TBL] [Abstract][Full Text] [Related]
7. Molecular modeling of purinergic receptor P2Y12 and interaction with its antagonists.
Zhan C; Yang J; Dong XC; Wang YL
J Mol Graph Model; 2007 Jul; 26(1):20-31. PubMed ID: 17110146
[TBL] [Abstract][Full Text] [Related]
8. An approach to peptide-based ATP receptors by a combination of random selection, rational design, and molecular imprinting.
Matsui J; Nagano J; Miyoshi D; Tamaki K; Sugimoto N
Biosens Bioelectron; 2009 Nov; 25(3):563-7. PubMed ID: 19497730
[TBL] [Abstract][Full Text] [Related]
9. Cytoprotection against oxidative stress-induced damage of astrocytes by extracellular ATP via P2Y1 receptors.
Shinozaki Y; Koizumi S; Ishida S; Sawada J; Ohno Y; Inoue K
Glia; 2005 Jan; 49(2):288-300. PubMed ID: 15494980
[TBL] [Abstract][Full Text] [Related]
10. Crystal structure of allo-Ile(A2)-insulin, an inactive chiral analogue: implications for the mechanism of receptor binding.
Wan ZL; Xu B; Chu YC; Katsoyannis PG; Weiss MA
Biochemistry; 2003 Nov; 42(44):12770-83. PubMed ID: 14596591
[TBL] [Abstract][Full Text] [Related]
11. Diastereoselectivity of the P2Y11 nucleotide receptor: mutational analysis.
Ecke D; Fischer B; Reiser G
Br J Pharmacol; 2008 Dec; 155(8):1250-5. PubMed ID: 18820714
[TBL] [Abstract][Full Text] [Related]
12. Extracellular ATP activates ERK1/ERK2 via a metabotropic P2Y1 receptor in a Ca2+ independent manner in differentiated human skeletal muscle cells.
May C; Weigl L; Karel A; Hohenegger M
Biochem Pharmacol; 2006 May; 71(10):1497-509. PubMed ID: 16533496
[TBL] [Abstract][Full Text] [Related]
13. Inhibition of Ca2+ signaling and glucagon secretion in mouse pancreatic alpha-cells by extracellular ATP and purinergic receptors.
Tudurí E; Filiputti E; Carneiro EM; Quesada I
Am J Physiol Endocrinol Metab; 2008 May; 294(5):E952-60. PubMed ID: 18349114
[TBL] [Abstract][Full Text] [Related]
14. Adenosine 5'-O-(1-boranotriphosphate) derivatives as novel P2Y(1) receptor agonists.
Nahum V; Zündorf G; Lévesque SA; Beaudoin AR; Reiser G; Fischer B
J Med Chem; 2002 Nov; 45(24):5384-96. PubMed ID: 12431066
[TBL] [Abstract][Full Text] [Related]
15. Pharmacological profiles of cloned mammalian P2Y-receptor subtypes.
von Kügelgen I
Pharmacol Ther; 2006 Jun; 110(3):415-32. PubMed ID: 16257449
[TBL] [Abstract][Full Text] [Related]
16. Role of the extracellular loops of G protein-coupled receptors in ligand recognition: a molecular modeling study of the human P2Y1 receptor.
Moro S; Hoffmann C; Jacobson KA
Biochemistry; 1999 Mar; 38(12):3498-507. PubMed ID: 10090736
[TBL] [Abstract][Full Text] [Related]
17. Structure and ligand-binding site characteristics of the human P2Y11 nucleotide receptor deduced from computational modelling and mutational analysis.
Zylberg J; Ecke D; Fischer B; Reiser G
Biochem J; 2007 Jul; 405(2):277-86. PubMed ID: 17338680
[TBL] [Abstract][Full Text] [Related]
18. A novel computational analysis of ligand-induced conformational changes in the ATP binding sites of cyclin dependent kinases.
Subramanian J; Sharma S; B-Rao C
J Med Chem; 2006 Sep; 49(18):5434-41. PubMed ID: 16942017
[TBL] [Abstract][Full Text] [Related]
19. Molecular docking-based study of vasopressin analogues modified at positions 2 and 3 with N-methylphenylalanine: influence on receptor-bound conformations and interactions with vasopressin and oxytocin receptors.
Slusarz MJ; Sikorska E; Slusarz R; Ciarkowski J
J Med Chem; 2006 Apr; 49(8):2463-9. PubMed ID: 16610789
[TBL] [Abstract][Full Text] [Related]
20. Expression of purinergic P2Y receptor subtypes by INS-1 insulinoma beta-cells: a molecular and binding characterization.
Lugo-Garcia L; Filhol R; Lajoix AD; Gross R; Petit P; Vignon J
Eur J Pharmacol; 2007 Jul; 568(1-3):54-60. PubMed ID: 17509560
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
